Feasibility Assessment of Facilitated Subcutaneous Immunoglobulin 1.0 G/Kg with Abbreviated Dose Ramp-Up and without Ramp-Up: A Phase 1 Tolerability and Safety Study in Healthy Adults (P6-4.003)
Zhaoyang Li(Yangpu Hospital of Tongji University), Leman Yel(Children's Hospital of Philadelphia), Kimberly Duff(Takeda (United States)), Enrique Rivera García(Universidad de Granada), Juan Carlos Rondón(Clinical Pharmacology of Miami), Dirk Lindner(Takeda (United States)), András Nagy(University of Szeged), Hakan Ay(Takeda (United States)), Noor M. Khaskhely(Takeda (United States))
Cited by 0
Related Papers
‘Footprints’ of Transient Ischemic Attacks: A Diffusion-Weighted MRI Study
|Cerebrovascular Diseases|2002|122
Electrical Stimulation of the Vagus Nerve Dermatome in the External Ear is Protective in Rat Cerebral Ischemia
|Brain stimulation|2014|92
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms
|Cardiovascular Drugs and Therapy|2024|38